Friday, 4 October 2013

Tetraphase to Present New Data at IDWeek on Eravacycline’s Potential Activity in Treating Serious Respiratory Infections « New Drug Approvals

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)